DEBRA Research and LEO Pharma enter strategic partnership to advance treatments for rare skin diseases: Munich, Germany Thursday, February 6, 2025, 10:00 Hrs [IST] DEBRA Research ...

German non-profit organization DEBRA Research GmbH, supporting those affected by epidermolysis bullosa (EB), and Denmark’s LEO Pharma announced a non-exclusive strategic partnership.

DEBRA Research and LEO Pharma announce strategic partnership to enhance treatments for Epidermolysis Bullosa (EB), a rare skin disease with no approved treatment options ...

A class action settlement has been reached in Stewart v. LEO Pharma Inc. et al, S.C.B.C. No. S2010053 (the "Claim"). The British Columbia Supreme Court has certified the class action for the purpose ...

Financial writer recommends Merck & Co., Inc. as a strong healthcare stock despite recent challenges, citing strong potential ...

(IN BRIEF) Stadler has been contracted to install a new traction system for Leo Express, a private Central European transport company, following recent rail infrastructure upgrades in the Czech ...

Stadler has been contracted to install a new traction system for Leo Express, a private Central European transport company, following recent rail i ...

The biotech sector in 2025 presents a landscape brimming with both opportunities and challenges. The industry is being shaped ...

The deal replaces a previous, $6 billion agreement that was rejected last July by the Supreme Court because it would have ...

LEO Pharma will be gaining the rights to commercialise Junshi Biosciences’ toripalimab in Europe under a new distribution and ...

Junshi Biosciences enters distribution and marketing partnership with LEO Pharma for toripalimab in Europe: Shanghai, China Wednesday, January 22, 2025, 14:00 Hrs [IST] Shanghai J ...

Leo Pharma has stepped up to commercialize toripalimab in Europe, inking a deal with Shanghai Junshi Biosciences to secure ...